| scholarly article | Q13442814 |
| P2093 | author name string | A H Jan Danser | |
| Anton H van den Meiracker | |||
| Langeza Saleh | |||
| Koen Verdonk | |||
| Willy Visser | |||
| P2860 | cites work | The HELLP syndrome: clinical issues and management. A Review | Q21261342 |
| ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1 | Q24317184 | ||
| Endothelin converting enzyme (ECE) activity in human vascular smooth muscle | Q24318736 | ||
| The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes | Q24339000 | ||
| L-arginine infusion reduces blood pressure in preeclamptic women through nitric oxide release | Q28372851 | ||
| Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats | Q28571017 | ||
| Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor | Q28580331 | ||
| Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice | Q28591495 | ||
| Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1 | Q28593256 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Differential effects of endothelin A and B receptor antagonism on fetal growth in normal and nitric oxide-deficient rats | Q32062851 | ||
| Expectant management of severe preeclampsia remote from term | Q33714163 | ||
| Progesterone blunts vascular endothelial cell secretion of endothelin-1 in response to placental ischemia | Q33736407 | ||
| New developments in the pathogenesis of preeclampsia | Q33935675 | ||
| Downregulation of microvascular endothelial type B endothelin receptor is a central vascular mechanism in hypertensive pregnancy | Q34051646 | ||
| Human pulmonary circulation is an important site for both clearance and production of endothelin-1 | Q71613816 | ||
| Endothelins | Q71874242 | ||
| A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats | Q72059493 | ||
| The endothelin system. A new target for therapeutic intervention | Q72285025 | ||
| Clearance of circulating endothelin-1 by ETB receptors in rats | Q72340095 | ||
| Expression of the three endothelin genes and plasma levels of endothelin in pre-eclamptic and normal gestations | Q72561514 | ||
| Hepatic effects of endothelin: metabolism of [125I]endothelin-1 by liver-derived cells | Q72860859 | ||
| Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure | Q73567364 | ||
| Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas | Q73892819 | ||
| Expression of endothelin-1 and endothelin-converting enzyme-1 mRNAs and proteins in failing human hearts | Q74573005 | ||
| Cardiotrophin-1 stimulates endothelin-1 via gp130 in vascular endothelial cells | Q74619541 | ||
| A STUDY OF THE SPIRAL ARTERIES OF THE DECIDUA BASALIS IN NORMOTENSIVE AND HYPERTENSIVE PREGNANCIES | Q76788299 | ||
| Plasma endothelin and big endothelin levels in women with severe preeclampsia or HELLP-syndrome | Q77747635 | ||
| Pharmacological knockout of endothelin ET(A) receptors | Q79272748 | ||
| [Weibel-Palade bodies: unique secretory organelles within endothelial cells] | Q80595326 | ||
| Endothelin receptor antagonists | Q81340191 | ||
| Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature | Q81423834 | ||
| The vascular endothelial growth factor receptor inhibitor sunitinib causes a preeclampsia-like syndrome with activation of the endothelin system | Q84353342 | ||
| Treatment of hypertension and renal injury induced by the angiogenesis inhibitor sunitinib: preclinical study | Q85243983 | ||
| Serum levels of ET-1, M30, and angiopoietins-1 and -2 in HELLP syndrome and preeclampsia compared to controls | Q85518802 | ||
| Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide | Q34243673 | ||
| Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action | Q34305617 | ||
| Purification and characterization of endothelin-converting enzyme from rat lung. | Q34358151 | ||
| Latest advances in understanding preeclampsia | Q34425288 | ||
| A study of angiotensin II pressor response throughout primigravid pregnancy | Q34512573 | ||
| Biogenesis and exocytosis of Weibel-Palade bodies. | Q34589219 | ||
| Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. | Q34702420 | ||
| Pre-eclampsia: more than pregnancy-induced hypertension | Q34726951 | ||
| Function of the endothelin(B) receptor in cardiovascular physiology and pathophysiology | Q34874953 | ||
| Role of placenta in preeclampsia. | Q35065105 | ||
| Endothelin inhibits renin release from juxtaglomerular cells via endothelin receptors A and B via a transient receptor potential canonical-mediated pathway | Q35094200 | ||
| Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease | Q35143007 | ||
| Subclassification of preeclampsia | Q35196220 | ||
| Immunological aspects of pre-eclampsia | Q35535852 | ||
| Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice | Q35701236 | ||
| Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia | Q35715914 | ||
| Historical review: Endothelin | Q35737648 | ||
| Physiology and pharmacology of endothelins | Q35849117 | ||
| Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi | Q35873974 | ||
| Effects of selective ETB-receptor stimulation on arterial, venous and capillary functions in cat skeletal muscle | Q35874585 | ||
| Treatment of pulmonary arterial hypertension | Q35905944 | ||
| L-arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant rats | Q35950303 | ||
| Endothelin-1: the yin and yang on vascular function. | Q36512799 | ||
| Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats | Q36683260 | ||
| Preeclampsia and angiogenic imbalance | Q36971766 | ||
| VEGF inhibition, hypertension, and renal toxicity | Q37103555 | ||
| The heart during pregnancy | Q37242100 | ||
| Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? | Q37369599 | ||
| Role of Endothelin-1/Endothelin-A receptor-mediated signaling pathway in the aortic arch patterning in mice | Q37386882 | ||
| Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
| Endothelin in brain: receptors, mitogenesis, and biosynthesis in glial cells | Q37723949 | ||
| Endothelin--biology and disease | Q37751103 | ||
| Mechanism of hypertension and proteinuria during angiogenesis inhibition: evolving role of endothelin-1. | Q38065814 | ||
| The renin-angiotensin-aldosterone system in pre-eclampsia: the delicate balance between good and bad. | Q38176651 | ||
| Endothelin receptor antagonists in clinical research--lessons learned from preclinical and clinical kidney studies | Q38194365 | ||
| Vascular endothelial growth factor-A and aldosterone: relevance to normal pregnancy and preeclampsia | Q39185420 | ||
| Endothelin-1 triggers placental oxidative stress pathways: putative role in preeclampsia | Q40433104 | ||
| Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. | Q40576701 | ||
| Salt-sensitive hypertension in endothelin-B receptor-deficient rats | Q40716791 | ||
| Regulation of endothelin-B receptor mRNA expression in human endothelial cells by cytokines and growth factors | Q41041736 | ||
| Association studies suggest a key role for endothelin-1 in the pathogenesis of preeclampsia and the accompanying renin-angiotensin-aldosterone system suppression | Q41078021 | ||
| The effect of angiotensin II on platelet intracellular free calcium concentration in human pregnancy | Q41083038 | ||
| Polar secretion of endothelin-1 by cultured endothelial cells | Q41129249 | ||
| Endothelins in the normal and diseased kidney | Q41323358 | ||
| Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin-1 secretion | Q42475050 | ||
| Effects of endothelins on renin secretion from isolated mouse renal juxtaglomerular cells | Q42488649 | ||
| Localization and production of immunoreactive endothelin-1 in the trophoblast of human placenta | Q42511074 | ||
| Nitric oxide inhibits endothelin-1 production through the suppression of nuclear factor kappa B. | Q42525112 | ||
| Hypertension Induced by the Tyrosine Kinase Inhibitor Sunitinib Is Associated With Increased Circulating Endothelin-1 Levels | Q42928512 | ||
| Effects of angiotensin metabolites in the coronary vascular bed of the spontaneously hypertensive rat: loss of angiotensin II type 2 receptor-mediated vasodilation | Q43212328 | ||
| Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. | Q43576536 | ||
| Dietary supplementation with L-arginine or placebo in women with pre-eclampsia | Q44695130 | ||
| Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia | Q44809422 | ||
| Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries | Q44885241 | ||
| Effect of the putative novel selective ETA-receptor antagonist HJP272, a 1,3,6-trisubstituted-2-carboxy-quinol-4-one, on infection-mediated premature delivery | Q44887023 | ||
| Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans | Q44917492 | ||
| Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia | Q45215867 | ||
| Insulin stimulates endothelin binding and action on cultured vascular smooth muscle cells | Q46205099 | ||
| Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. | Q46339760 | ||
| Introducing a mouse model for pre-eclampsia: adoptive transfer of activated Th1 cells leads to pre-eclampsia-like symptoms exclusively in pregnant mice | Q46347472 | ||
| Plasma nitric oxide, endothelin-1 and urinary nitric oxide and cyclic guanosine monophosphate levels in hypertensive pregnant women | Q46590664 | ||
| Endothelin ETA receptor regulates signaling and ANF gene expression via multiple G protein-linked pathways | Q46873898 | ||
| Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies | Q46878600 | ||
| Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene | Q47625987 | ||
| Plasma nitric oxide, endothelin-1, arginase and superoxide dismutase in pre-eclamptic women. | Q51436935 | ||
| Developmental toxicity and toxicokinetics of two endothelin receptor antagonists in rats and rabbits. | Q52179391 | ||
| Differences in mRNA expression of endothelin-1, c-fos and c-jun in placentas from normal pregnancies and pregnancies complicated with preeclampsia and/or intrauterine growth retardation. | Q52197249 | ||
| Endothelin-1 and big endothelin-1 levels in normal term pregnancy and in preeclampsia. | Q52287211 | ||
| Inducible human endothelin-1 overexpression in endothelium raises blood pressure via endothelin type A receptors. | Q53645099 | ||
| Differential regulation of ET(A) and ET(B) in the renal tissue of rats with compensated and decompensated heart failure. | Q53860548 | ||
| ETA and ETB receptors mediate contraction to endothelin-1 in renal artery of aging SHR. Effects of FR139317 and bosentan. | Q54176295 | ||
| Evidence for endothelin-induced renal vasoconstriction independent of ETA receptor activation. | Q54251572 | ||
| Greater Sensitivity of Blood Pressure Than Renal Toxicity to Tyrosine Kinase Receptor Inhibition With Sunitinib. | Q54258004 | ||
| Long-lasting vasoconstriction and efficient regional extraction of endothelin-1 in human splanchnic and renal tissues. | Q54284783 | ||
| Balance of antiangiogenic and angiogenic factors in the context of the etiology of preeclampsia. | Q54328595 | ||
| Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. | Q54570213 | ||
| The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia. | Q54599986 | ||
| Pre-eclampsia | Q56019568 | ||
| Dysregulation of the Circulating and Tissue-Based Renin-Angiotensin System in Preeclampsia | Q56981959 | ||
| Maternal plasma level of endothelin is increased in preeclampsia | Q67973452 | ||
| Effect of endothelin-1 in man | Q68499122 | ||
| Two distinct types of endothelin receptors are present on chick cardiac membranes | Q69351759 | ||
| P433 | issue | 5 | |
| P921 | main subject | pathogenesis | Q372016 |
| pre-eclampsia | Q61335 | ||
| P304 | page(s) | 282-293 | |
| P577 | publication date | 2016-01-10 | |
| P1433 | published in | Therapeutic advances in cardiovascular disease | Q26842002 |
| P1476 | title | The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia | |
| P478 | volume | 10 |
| Q49887672 | Altered Endothelial Nitric Oxide Signaling as a Paradigm for Maternal Vascular Maladaptation in Preeclampsia |
| Q61806000 | Discovery of Pathologic GPCR Aggregation |
| Q92220008 | Dopamine in the Pathophysiology of Preeclampsia and Gestational Hypertension: Monoamine Oxidase (MAO) and Catechol-O-methyl Transferase (COMT) as Possible Mechanisms |
| Q47754286 | Endothelin type B (ETB) receptors: friend or foe in the pathogenesis of pre-eclampsia and future cardiovascular disease (CVD) risk? |
| Q36902613 | Endothelin, sex, and pregnancy: unique considerations for blood pressure control in females |
| Q49600503 | Immune regulation of systemic hypertension, pulmonary arterial hypertension, and preeclampsia: shared disease mechanisms and translational opportunities |
| Q49873606 | Inverse correlation between maternal plasma asymmetric dimethylarginine (ADMA) and birthweight percentile in women with impaired placental perfusion: circulating ADMA as an NO-independent indicator of fetal growth restriction? |
| Q92962644 | Is urinary excretion of plasminogen associated with development of pre-eclampsia? An observational, explorative case-control study |
| Q91815900 | Pre-eclampsia: pathogenesis, novel diagnostics and therapies |
| Q91728181 | Predicting peripartum blood transfusion: focusing on pre-pregnancy characteristics |
| Q64926884 | Preeclampsia: Novel Mechanisms and Potential Therapeutic Approaches. |
| Q39384416 | Recent Advances in Hypertension and Cardiovascular Toxicities With Vascular Endothelial Growth Factor Inhibition. |
| Q37067705 | Role of agonistic autoantibodies against type-1 angiotensin II receptor in the pathogenesis of retinopathy in preeclampsia |
| Q47422599 | Serum endothelin-1 and placental alkaline phosphatase levels in placenta percreta and normal pregnancies |
| Q90533738 | Sex differences in redox homeostasis in renal disease |
| Q57168766 | Sex differences in stroke: Challenges and opportunities |
| Q64935754 | Sex-Specific Contributions of Endothelin to Hypertension. |
| Q58708934 | The direct and sustained consequences of severe placental hypoxia on vascular contractility |
| Q36315177 | The impact of laser surgery on angiogenic and anti-angiogenic factors in twin-twin transfusion syndrome: a prospective study |
| Q28070253 | Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia |
Search more.